Viewing Study NCT00360334


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-02-26 @ 10:26 PM
Study NCT ID: NCT00360334
Status: COMPLETED
Last Update Posted: 2015-04-07
First Post: 2006-08-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetes View
None exenatide View
None insulin glargine View
None Lilly View
None Amylin View